Advertisement
Screener

BIOMERICA INC (BMRA) Accounts Receivable, before Allowance for Credit Loss

2.8 / 5 stars · 68/120 Roast Me

BIOMERICA INC Accounts Receivable, before Allowance for Credit Loss

BIOMERICA INC (BMRA) had Accounts Receivable, before Allowance for Credit Loss of $772.00 thousand as of 2023-02-28, per its 10-Q filed 2023-04-14.

Discontinued › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss

us-gaap:AccountsReceivableGross · last filed 2023-04-14

  • 2023-02-28: Accounts Receivable, before Allowance for Credit Loss $772.00K.
  • 2022-11-30: Accounts Receivable, before Allowance for Credit Loss $1.37M.
  • 2022-08-31: Accounts Receivable, before Allowance for Credit Loss $1.31M.
  • 2022-05-31: Accounts Receivable, before Allowance for Credit Loss $927.00K.
Period endAccounts Receivable, before Allowance for Credit Loss
2023-02-28$772.00K
10-Q · filed 2023-04-14
2022-11-30$1.37M
10-Q · filed 2023-01-13
2022-08-31$1.31M
10-Q · filed 2022-10-13
2022-05-31$927.00K
10-Q · filed 2023-04-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92